Generics

Hafrun succeeds Brian Hoffmann, who will leave Hikma effective May 1.

Teva will continue to commercialize adalimumab-ryvk under the Simlandi brand in the U.S.

An Avalere analysis finds Part D prescription drug plans continue to increase patient copays for generics by moving them to higher tiers.

Mirabegron is indicated for the treatment of overactive bladder with symptoms relating to urgency and urinary frequency.

Fesoterodine Fumarate ER Tablets are indicated for the treatment of overactive bladder in adults.

The U.S., Italy and Japan accounted for more than 60% of physicians who held strong opinions on whether patients should have the option to choose between branded or generic drugs.

If the merger is completed, Taro will become a privately held company and its shares will no longer be listed on the NYSE.

Selarsdi (ustekinumab-aekn) injection for subcutaneous use is for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis.